Interestingly, the frequency of the TNFRI promoter −1135C allele was also significantly increased and the −201T allele decreased in EBV-positive PTLD compared with transplant and healthy controls. This evidence concerns the gene TNFRSF1A and post-transplant lymphoproliferative disease.